Abrahmsen Lars B.
Insider CIK 1789039 · APRE SVP, Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2022-03-10 | 2022-03-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2022-03-10 | 2022-03-14 | 24,700 | — | $0 | 43,700 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise deriv | 2021-10-01 | 2021-10-05 | 50,000 | — | $0 | 30,587 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise | 2021-10-01 | 2021-10-05 | 50,000 | $0.92 | $46.0K | 69,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2021-10-01 | 2021-10-05 | 50,000 | $4.89 | $244.5K | 19,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise deriv | 2021-09-20 | 2021-09-22 | 25,000 | — | $0 | 80,587 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise | 2021-09-20 | 2021-09-22 | 25,000 | $0.92 | $23.0K | 44,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2021-09-20 | 2021-09-22 | 25,000 | $4.97 | $124.3K | 19,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2021-02-25 | 2021-03-01 | 82,000 | — | $0 | 82,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2021-02-25 | 2021-03-01 | 19,000 | — | $0 | 19,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2020-03-24 | 2020-03-26 | 31,600 | — | $0 | 31,600 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2019-10-07 | 2019-10-07 | 77,630 | — | $0 | 77,630 | SEC↗ |